Skip to main content
Article
Addressing Physician Barriers to Administering Cyclin-dependent Kinases 4 and 6 Inhibitors in First-line Treatment of Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast cancer
Cancer Management and Research (2019)
  • Reshma Mahtani, Baptist Health South Florida
  • Charles L. Vogel, University of Miami
Publication Date
2019
Citation Information
Reshma Mahtani and Charles L. Vogel. "Addressing Physician Barriers to Administering Cyclin-dependent Kinases 4 and 6 Inhibitors in First-line Treatment of Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast cancer" Cancer Management and Research Vol. 11 (2019) p. 513 - 524
Available at: http://works.bepress.com/reshma-mahtani/87/